Scientia Clinical Research is an FDA audited, not-for-profit early phase clinical trial unit. Scientia is co-located within the Prince of Wales Hospital in Randwick which offers a full range of clinical specialties allowing collaboration with KOLS in various specialities which provides access to patient and healthy volunteers for clinical trials.

SCR conducts approximately 50-60 clinical trials per year, the majority being First Time In Human (FTIH) SAD/MAD, food effect, drug-drug interaction, ethnopharmacology, biosimilar, formulation and other specialty studies incorporating a range of pharmacodynamic markers such as Flow Cytometry and Cytokine analysis.

Why work with us

In addition to our operational excellence and track record of successfully recruiting every cohort in 2024, Scientia also has the ability to manufacture finished investigational product from active pharmaceutical ingredients through our in-house and onsite Grade C Investigational Product Compounding Suite. These services have provided significant time and cost savings to our Sponsors which allows us to manage investigational product importation, receipt and labelling flexibly, depending on the unique requirements of every project.

The majority of our sponsors are small to mid-sized biotechnology companies but Scientia recognises the need to provide a high degree of attention and detail to each and every project.